Skip to Content


In the US, Stiripentol (stiripentol systemic) is a member of the drug class gamma-aminobutyric acid reuptake inhibitors and is used to treat Dravet Syndrome.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antiepileptic agent (adjunct)

Chemical Names

(RS,E)-4,4-Dimetyl-1-(3,4-metylendioxyphenyl)pent-1-en-3-ol (IUPAC)

1-Penten-3-ol, 1-(1,3-benzodioxol-5-yl)-4,4-dimetyl- (USAN)

4,4-Dimetyl-1-[(3,4-metylenedioxy)phenyl]-1-penten-3-ol (WHO)

Foreign Names

  • Stiripentolum (Latin)
  • Stiripentol (German)
  • Stiripentol (French)
  • Estiripentol (Spanish)

Generic Names

  • Stiripentol (OS: USAN, DCF, JAN)
  • BCX 2600 (Biocodex) (IS)
  • BRN 1313047 (IS)
  • EINECS 256-480-9 (IS)

Brand Names

  • Diacomit
    Biocodex, Belgium; Biocodex, Canada; Biocodex, Czech Republic; Biocodex, Denmark; Biocodex, Estonia; Biocodex, Spain; Biocodex, France; Biocodex, Lithuania; Biocodex, Latvia; Biocodex, Netherlands; Biocodex, Norway; Biocodex, Poland; Biocodex, Romania; Desitin, Germany; Desitin, Sweden; Desitin Arzneimittel GmbH, Finland; Link, New Zealand; Meiji Seika Pharma, Japan
  • Diacomit 250mg
    Zambon, Switzerland
  • Diacomit 500mg
    Zambon, Switzerland


DCFDénomination Commune Française
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.